Clinical Observation of Recombinant Human Vascular Endostatin Durative Transfusion Combined with Window Period Arterial Infusion Chemotherapy in the Treatment of 
Advanced Lung Squamous Carcinoma

Background and objective Lung cancer is one of the most common malignant tumors in China. The aim of this study is to observe the efficacy and safety of recombinant human vascular endostatin (endostar) durative transfusion combined with window period arterial infusion chemotherapy in the treatment o...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuan LV, Rong JIANG, Chunhua MA, Jinduo LI, Bin WANG, Liwei SUN, Ning MU
Médium:	Artigo
Jazyk:	Chinês
Vydáno:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-08-01
Edice:	Chinese Journal of Lung Cancer
Témata:	Lung neoplasms Recombinant human vascular endostatin Arterial infusion chemotherapy Adverse reactions
On-line přístup:	http://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.05
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!